Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 209-217

  Kurien, B T ^a   Newland, J ^a   Paczkowski, C ^a   Moore, K L ^a   Scofield, R Hal ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b NONE   (United States)

Author keywords

Anti Ro SS A; D1 antigen; Mass spectrometry; Neutropenia; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; MEMBRANE ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NEUTROPENIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034069044     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01195.x     Document Type: Article

References (53)

1. Nossent JC, Swaak AJG. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Quart J Med 1991; 80:605-12.
2. Goeckerman WH. Lupus erythematosus as a systemic disease. JAMA 1923; 80:542-7.
3. Michael SR, Vural IL, Bassen FA, Schaefer L. The hematological aspects of disseminated (systemic) lupus erythematosus. Blood 1951; 6:1059-72.
4. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954; 33:291-437.
5. Starkebaum G, Arend WP. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. Evidence for the presence of both soluble immune complexes and immunoglobulin G antibodies to neutrophils. J Clin Invest 1979; 64:902-12.
6. Rustagi PK, Currie MS, Logue GL. Complement-activating antineutrophil antibody in systemic lupus erythematosus. Am J Med 1985; 78:971-7.
7. Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus. Rheum Dis Clin N Am 1992; 18:337-58.
8. O'Brien CA, Wolin SL. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 1994; 8:2891-903.
9. Shi H, O'Brien CA, Van Horn DJ, Wolin SL. A misfolded form of 5S rRNA is complexed with the Ro and La autoantigens. RNA 1996; 2:769-84.
10. Farris AD, Gross JK, Hanas JS, Harley JB. Genes for murine Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures and are unlinked on mouse chromosome 6. Gene 1996; 174:35-42.
11. Hendrick JP, Wolin SL, Rinke J, Lerner MR, Steitz JA. Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol 1981; 1:1138-49.
12. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, Yamagata H, Arnett FC. Anti-Ro/SSA and anti-La/SSB in patients with Sjögren's syndrome. Arthritis Rheum 1986; 29:196-206.
13. Ben-Chetrit E, Chan EK, Sullivan KF, Tan EM. A 52-kD protein is a novel component of the SSA/Ro antigenic particle. J Exp Med 1988; 167:1560-71.
14. Boire G, Gendron M, Monast N, Bastin B, Ménard HA. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995; 100:489-98.
15. Peek R, Pruijn GJ, van der Kamp AJ, van Venrooij WJ. Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J Cell Sci 1993, 106:929-35.
16. Kelekar A, Saitta MR, Keene JD. Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest 1994; 93:1637-44.
17. Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: anti-60 kD antibodies are mainly directed to the native protein; anti-52kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992; 14:57-65.
18. Itoh Y, Itoh K, Frank MB, Reichlin M. Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity 1992; 14:85-95.
19. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum 1989; 32:826-36.
20. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983; 98:155-9.
21. de Rooij DJ, van de Putte LB, Habets WJ, Verbeek AL, van Venrooij WJ. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serologic associations in rheumatic diseases. Scand J Rheumatol 1988; 17:353-64.
22. Boire G, Menard HA, Gendron M, Lussier A, Myhal D. Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol 1993; 20:1654-60.
23. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
24. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60 kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996; 156:4059-66.
25. Mamula MJ, Fox OF, Yamagata H, Harley JB. The Ro/SSA autoantigen as an immunogen: some anti-Ro/SSA antibody binds immunoglobulin G. J Exp Med 1986; 164:1889-901.
26. Yamagata H, Harley JB, Reichlin M. Molecular properties of the Ro(SSA) antigen and enzyme-linked immunosorbant assay for quantitation of antibody. J Clin Invest 1984; 74:625-33.
27. Dickey WD, van Egmond JE, Hardgrave KL, Harley JB, Scofield RH. Presence of anti-La (SS-B) is associated with binding to the 13 kD carboxyl terminus of 60 kD Ro(SS-A) in systemic lupus erythematosus. J Invest Dermatol 1993; 100:412-6.
28. 2-generating NADPH oxidase. J Biol Chem 1990; 265:8426-30.
29. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992; 118:445-56.
30. Itoh Y, Rader MD, Reichlin M. Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: evidence of the four antigenically distinct forms. Clin Exp Immunol 1990; 81:45-51.
31. Kurien BT, Scofield RH. Multiple immunoblots after non-electrophoretic bidirectional transfer of a single SDS-PAGE gel with multiple antigens. J Immunol Methods 1997; 205:91-94.
32. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 1999; 133:15-22.
33. Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72:1375-81.
34. Dong Q, Ludgate M, Vassart G. Towards an antigenic map of thyroglobulin: identification of ten epitope-bearing sequences within the primary structure of thyroglobulin. J Endocrinol 1989; 122:169-76.
35. Ross PV, Koenig RJ, Arscott P, Ludgate M, Waier M, Nelson CC, Kaplan MM, Baker Jr Jr. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. J Clin Endocrinol Metab 1993; 77:433-8.
36. Bernard NF, Nygen TN, Tyutyunikov A et al. Antibodies against ID, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity. Clin Immunol Immunopathol 1994; 70:225-33.
37. Zhang ZG, Dong Q, Rodien P et al. Antibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a full length 64 kDa eye muscle membrane protein which is also expressed in the thyroid. Autoimmunity 1992; 13:151-7.
38. Scofield RH. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren's syndrome. Clin Exp Rheumatol 1996; 14:321-30.
39. Foster H, Fay A, Kelly C, Charles P, Walker D, Griffiths I. Thyroid disease and other autoimmune phenomena in a family study of primary Sjögren's syndrome. Br J Rheumatol 1993; 32:36-40.
40. Kausman D, Isenberg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol 1995; 34:361-4.
41. Vianna JL, Haga HJ, Asherson RA, Swana G, Hughes GRV. A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol 1991; 18:1193-5.
42. Weetman AP, Walport MJ. The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 1987; 26:359-61.
43. Jonsson H, Nived O, Sturfelt G. Thyroid disorders are related to secondary Sjögren's syndrome in unselected systemic lupus erythematosus patients (letter). Arthritis Rheum 1988; 31:1079-80.
44. Jonsson H, Nived O, Sturfelt G. Thyroid disorders in systemic lupus erythematosus are associated with secondary Sjögren's syndrome (letter). Ann Rheum Dis 1987; 46:349.
45. Mamula MJ, Harley JB. Anti-Ro autoantibody with cross-reactive binding to the heavy chain of immunoglobulin G. Yale J Biol Med 1992; 65:277-87.
46. Ohnishi K, Ebling FM, Mitchell B, Singh RR, Hahn BH, Tsao BP. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol 1994; 6:817-30.
47. Koren E, Koscec M, Wolfson-Reichlin M, Ebling FM, Tsao B, Hahn BH, Reichlin M. Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. J Immunol 1995; 154:4857-64.
48. Harley JB, Kaine JL, Fox OF, Reichlin M, Gruber B. Ro(SSA) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum 1985; 28:1321-5.
49. Garcia S, Nascimento JHM, Bonfa E, Levy R, Olivera SF, Tavares AV, de Carvalho AC. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 1994; 93:718-24.
50. Boutjdir M, Chen L, Zhang ZH et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80:354-62.
51. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin VR, Wolfson-Reichlin M, Lee LA. Concentration of autoantibodies to native 60-kd Ro/SSA and denatured 52-kd Ro/SSA in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994; 37:1698-703.
52. Lee LA, Gaither KK, Coulter SN, Morris DA, Harley JB. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro(SSA) autoantibodies into human skin-grafted mice. J Clin Invest 1989; 83:1556-62.
53. Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stasny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982; 97:664-71.